Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- growth and patterning
- Genetic screens for growth regulators
- Identification of Wts
- Identification of additional tumor suppressors
- Hippo pathway regulates diap1 transcription
- Hpo/Sav interactions
- The Hippo kinase cascade
- Identification of Yki as a Wts-binding protein
- Yki is the fly homologue of YAP
- Phosphorylation of Yki by Wts
- Hippo pathway negatively regulates Yki activity
- Yki regulates organ size in Drosophila
- Yki regulates diap1 transcription
- Basic organization of the Hippo kinase cascade
- Hippo signaling inactivates Yki by phosphorylation
- Hippo signaling loss and Yki nuclear accumulation
- The role of Yki S168 phosphorylation in vivo
- Introduction to the mammalian Hippo pathway
- Delineation of a mammalian Hippo pathway
- Hippo pathway in Drosophila and mammals
- Transgenic YAP model
- YAP is a growth promoting gene in mammals
- YAP promotes cell proliferation genes expression
- YAP stimulates expression of anti-apoptotic genes
- Conservation of the Hippo pathway
- Over expression of YAP causes tumors in mice
- YAP over expression prevalence in human tumors
- Summary
- Acknowledgments
Topics Covered
- Genetic screens for tumor suppressors in Drosophila
- Identification of the Warts tumor suppressor
- Identification of Hippo tumor suppressor and elucidation of the Hippo kinase cascade
- Discovery of Yorkie as the nuclear effector of the Hippo pathway
- Mechanism of Yorkie inactivation by phosphorylation
- Conservation of the Hippo kinase cascade in mammals
- The role of the Hippo pathway in mammalian organ size control and tumorigenesis
Links
Series:
Categories:
Talk Citation
Pan, D. (2018, May 31). Control of tissue growth: elucidation of the Hippo signaling pathway [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/RCKR7141.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Duojia Pan has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Control of tissue growth: elucidation of the Hippo signaling pathway
A selection of talks on Genetics & Epigenetics
Transcript
Please wait while the transcript is being prepared...
0:00
My name is DJ Pan, I am a faculty member
in the Department of Molecular Biology and
Genetics at Johns Hopkins
University School of Medicine.
In today's lecture I will
review recent studies
in the fruit fly Drosophila concerning
the control of tissue growth.
In particular my lecture will focus
on the recent elucidation of a novel
signalling pathway which we
call the 'Hippo pathway'.
It's my hope that this lecture will
provide you with an example of how one can
use the fruit fly as a powerful model
to understand the basic mechanisms of
human disease,
including the mechanisms of human cancer.
0:41
During organogenesis, growth and
patterning must be independently
coordinated in order to generate
organs of reproducible size and shape.
Compared to our understanding
of pattern formation,
relatively less is known about how
the size of an organ is determined.
The compound eye of Drosophila is
an ideal system to study organ size,
since this organ is totally
dispensable for animal viability.
This means one can screen for
mutations that increase or
decrease the size of an eye
without worrying about
the detrimental effects of
the mutation on animal viability.
1:22
In the last decade, many Drosophila
labs have conducted genetic screens for
growth regulators of the compound
eye using mosaic flies.
The essence of these screens is to
generate, by mitotic recombination,
a cell that is homozygous for
a given mutation in an otherwise
heterozygous mutant background.
These screens are set up in such a way
that whenever a homozygous mutant
cell (designated here as minus
over minus or -/-) is generated,
a sibling cell is also generated which
has a plus over plus (+/+) genotype.
This pair of cells then proliferates
to generate two clones of cells next to
each other in the adult eye.
If a gene does not play
a role in tissue growth,
we might expect the mutant clone to be
of the same size as a sibling clone.
However if a gene normally is positively
required for tissue growth we
might expect the mutant clone to
be smaller than the sibling clone.
On the contrary, if a gene normally
plays a negative role in growth control
then we might expect a mutant clone
to be larger than the sibling clone.
This last class of overgrown mutation
represents what we call the tumor
suppressor genes.